BioSpectrum Asia - December 2019
BioSpectrum Asia - December 2019
Magzter GOLDã§èªã¿æŸé¡ãå©çšãã
1 åã®è³Œèªã§ BioSpectrum Asia ãš 8,500 ããã³ãã®ä»ã®éèªãæ°èãèªãããšãã§ããŸã  ã«ã¿ãã°ãèŠã
1 ã¶æ $9.99
1 幎$99.99 $49.99
$4/ã¶æ
ã®ã¿è³Œèªãã BioSpectrum Asia
1幎 $10.99
ä¿å 7%
ãã®å·ãè³Œå ¥ $0.99
ãã®åé¡ã§
Collaboration â Sustainable Solution for Big (Pharma & Tech)
According to an EY report, between 2013 and 2017, Alphabet (Googleâs parent company) filed 186 health-related patents, Microsoft â 73 and Apple â 54, which is a 38 per cent increase in the number of such patents by these three companies every two years. The report further noted that such a competition poses a new challenge to pharma, and argued that health companies should capitalise on the data they gather to create digital solutions helping patients with their health. Many of the challenges that healthcare industry can be solved with the availability of state-of-the-art digital health solutions. Moving forward it will become imperative for pharma and tech firms to collaborate and this joint collaboration will create a new market that has more than enough potential for both sides.
COLLABORATION â SUSTAINABLE SOLUTION FOR BIG (PHARMA & TECH)
According to an EY report, between 2013 and 2017, Alphabet (Googleâs parent company) filed 186 health-related patents, Microsoft â 73 and Apple â 54, which is a 38 per cent increase in the number of such patents by these three companies every two years.
10+ mins
More biotech companies moving into ASX 200
More biotech companies are moving into the Australian Securities Exchange (ASX) 200, with two new companies recently joining the list: PolyNovo (PNV) and Avita Medical (AVH). This movement demonstrates the healthy biotech pipeline in Australia, with more small to medium enterprises (SMEs) progressing through as the life sciences sector grows and matures.
3 mins
Asia Pacific region is beginning to endorse stem cell treatments
Transfiguring the face of medicine, Advancells was established in the year 2013.
8 mins
âWe started with making an impact with ANT surgical robotics to optimise procedures in medical industryâ
Share your experience of winning APAC MedTech innovator award.
2 mins
âVACOX stimulates natural physiological process to reduce healing time & cost associatedâ
Share your experience of winning one of the APAC MedTech innovator awards
2 mins
âWe are planning FDA submission for our clinical tool in early 2020â
Share your experience on winning Startup SG award and JLABS award
2 mins
Decoding healthcare in China
âTechfor goodâ is the vision and mission of Tencent, which believes that progressive technology can help humans unlock the mysteries of life.
4 mins
India has potential to emerge world leader in Biotechnology: Dr Harsh Vardhan
âIndia has the potential to emerge as the worldâs top industry destination in biotechnology sector.
4 mins
BioSpectrum Asia Magazine Description:
åºç瀟: MM Activ Sci-Tech Communication
ã«ããŽãªãŒ: Business
èšèª: English
çºè¡é »åºŠ: Monthly
BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:
* Biotechnology news and trends:Â BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews:Â The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development:Â BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews:Â The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events:Â BioSpectrum Asia covers biotechnology industry events from around the world.
BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.
- ãã€ã§ããã£ã³ã»ã«OK [ å¥çŽäžèŠ ]
- ããžã¿ã«ã®ã¿